LYRA - Lyra Therapeutics Inc. Net earnings per share (EPS TTM)

Symbol and logo of brand Lyra Therapeutics Inc. (LYRA)

R&D risks associated with implantable systems for ENT pathologies drive the volatility reflected in the 12-month net income per share chart for Lyra Therapeutics, Inc. (LYRA). The value of -22.70 captures the metric level while the company optimizes costs through contract manufacturing. Meanwhile, the pristine image of Lyra Therapeutics, Inc. (LYRA) in the field of local therapy provides long-term support for its market position.

LYRA (Lyra Therapeutics, Inc.) Net earnings per one share for the last twelve months history from 07/04/2022 to 03/28/2026

Lyra Therapeutics, Inc. - analytical breakdowns and key metrics (LYRA)

Basic company analysis:LYRA - Lyra Therapeutics
Mass-produced product of Lyra Therapeutics Inc

The stability of Lyra Therapeutics, Inc. (LYRA) is based on its authority as a developer of innovative local therapy systems for ENT organs. Drug delivery efficiency directly impacts capitalization, which is mathematically reflected in net earnings per share. This metric measures the real profitability of the business, adjusted for the total volume of issuance. Analyzing the EPS trend over the last 12 months allows investors to filter out market noise, helping them assess the risk balance and capital growth potential.

Competing companies

Haleon - Net earnings per share (EPS TTM)|Kenvue - Earnings per share for the last four quarters|VRNA: Net earnings per share (EPS TTM)|Jyong Biotech Corp - Earnings per share for the trailing year|LGND (Ligand Pharmaceuticals Incorporated) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months amneal.com AMRX|Earnings per share for the last twelve months Perrigo (PRGO)|ALVO (Alvotech SA) - Earnings per share for the trailing year|Earnings per share for the last twelve months Liquidia Technologies LQDA|Net earnings per share for the trailing year Galapagos Genomics|ANIP - Earnings per share for the last twelve months|MNKD - Net earnings per share (EPS TTM)|Amphastar Pharmaceuticals (AMPH) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Pacira BioSciences, Inc.|Net earnings per share for the last 12 months SPRY|TBPH: Earnings per share for the trailing year|Earnings per share for the last twelve months aquestive.com (AQST)|Net earnings per share (EPS TTM) scPharmaceuticals, Inc. (SCPH)|Earnings per share for the last twelve months tectonictx.com TECX|Earnings per share for the trailing year TNXP|SXTC - Earnings per share for the last twelve months|Net earnings per share for the last four quarters eupraxiapharma.com EPRX|BHST: Net earnings per share (EPS TTM)|EXOZ - Net earnings per share for the last four quarters|ORMP (oramed.com) - Net earnings per share (EPS TTM)|enterabio.com (ENTX) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) HYFT|ABVC (ABVC BioPharma Inc) - Earnings per share for the trailing year|Cumberland Pharmaceuticals - Net earnings per share for the last 12 months|quantumbiopharma.com (QNTM) - Net earnings per one share for the last twelve months|FibroGen Inc - Net earnings per share (EPS TTM)|Earnings per share for the trailing year TELO (Telomir Pharmaceuticals Inc)|RANI (Rani Therapeutics Holdings, Inc.) - Net earnings per share for the last 12 months|Net earnings per share for the last 12 months Synergy CHC Corporation|Earnings per share for the last twelve months Rallybio Corp|Lexaria Bioscience (LEXX) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Pulmatrix, Inc. (PULM)|Net earnings per share for the last four quarters Pheton|Earnings per share for the last twelve months Aptorum Group Limited APM|Impact BioMedical - Earnings per share for the last twelve months|TNF Pharmaceuticals - Net earnings per share (EPS TTM)|YCBD - Net earnings per share (EPS TTM)|PRFX: Net earnings per share (EPS TTM)|CYTO: Earnings per share for the last four quarters|LIPO (Lipella Pharma) - Net earnings per share (EPS TTM)|OPTN: Earnings per share for the trailing year|Net earnings per share (EPS TTM) PIRS|PROC (procapsgroup.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months Petros Pharmaceuticals, Inc. PTPI|Qilian International Holding - Earnings per share for the last twelve months|SLRN - Earnings per share for the last twelve months|Earnings per one share for the last 12 months TFFP